XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Operating Leases - Additional Information (Details)
3 Months Ended 9 Months Ended
Dec. 16, 2021
OfficeSuite
Nov. 17, 2021
USD ($)
Nov. 10, 2021
May 10, 2021
USD ($)
Jan. 27, 2021
OfficeSuite
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Aug. 31, 2023
USD ($)
Aug. 01, 2023
USD ($)
Dec. 31, 2022
USD ($)
Lessee Lease Description [Line Items]                        
Operating lease right-of-use assets           $ 13,195,000   $ 13,195,000       $ 5,580,000
Operating lease liability           53,111,000   53,111,000        
Contractual Obligation, to be Paid, Remainder of Fiscal Year           0   0        
Current portions of operating lease liability           3,439,000   3,439,000       4,045,000
Non-current portions of operating lease liability           $ 49,672,000   $ 49,672,000       $ 1,749,000
Remaining lease term on operating leases           110 months   110 months        
Weighted average incremental borrowing rate on operating lease           10.90%   10.90%        
Lease expense           $ 2,400,000 $ 1,700,000 $ 6,400,000 $ 5,000,000      
Variable lease payments           800,000 $ 300,000 1,800,000 $ 1,000,000      
Explora BioLabs, Inc                        
Lessee Lease Description [Line Items]                        
Operating lease right-of-use assets           0   0        
Operating lease liability           0   $ 0        
Lease Agreement                        
Lessee Lease Description [Line Items]                        
Lessee, operating lease, option to extend               The term of the lease is 44 months for the first office suite and 43 months for the second office suite with an option to extend the term for an additional two years on the same terms and conditions        
Number of office suites | OfficeSuite         2              
Operating lease right-of-use assets           13,200,000   $ 13,200,000        
Operating lease liability           53,100,000   $ 53,100,000        
First Office Suite                        
Lessee Lease Description [Line Items]                        
Operating lease commencement date     Nov. 10, 2021   Jul. 31, 2021              
Sublease expire date     Dec. 06, 2023                  
Second Office Suite                        
Lessee Lease Description [Line Items]                        
Operating lease commencement date         Aug. 31, 2021              
Embedded Lease Agreement | Laboratory For Cell And Gene Medicine                        
Lessee Lease Description [Line Items]                        
Finance lease maturity date       Apr. 30, 2023                
Fixed lease payments       $ 5,600,000                
License Service Agreement and Master Services Agreement | Explora BioLabs, Inc                        
Lessee Lease Description [Line Items]                        
Finance lease maturity date   Nov. 30, 2023                    
Fixed lease payments   $ 700,000                    
Bayside Lease [Member]                        
Lessee Lease Description [Line Items]                        
Term of contract 120 months                 20 months 20 months  
Office And Laboratory Space | OfficeSuite 85,165                      
Lessee, operating lease, option to extend               The term of the lease is 120 months with the option to extend the term up to an additional ten years.        
Operating lease liability           32,000,000   $ 32,000,000        
Leasehold improvements           27,200,000   27,200,000        
Leasehold tenant improvement allowance               14,900,000        
Leasehold improvements liability utilized and recorded           14,900,000   14,900,000        
Sublease payments                   $ 500,000 $ 500,000  
Sublease Income           $ 100,000   $ 100,000